Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Omega-5 Fatty Acid Supplement on Markers of Inflammation and Oxidative Stress in Patients With Severe Alcoholic Hepatitis Treated With Prednisone

NCT03732586 is registered in ClinicalTrials.gov with Hospital General Dr. Manuel Gea González as lead sponsor.

NCT NCT03732586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03732586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Omega-5 Fatty Acid Supplement on Markers of Inflammation and Oxidative Stress in Patients With Severe Alcoholic Hepatitis Treated With Prednisone
Lead sponsor
Hospital General Dr. Manuel Gea González
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2018
Completion date
May 22, 2023
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic hepatitis